Chemed Corp Stock News

Inflationary trend, increased logistics costs and higher employee-related expenses continue to hurt Chemed's (CHE) growth.

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks offers value i

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two companies is the best

Chemed Corporation's equity stock has declined since its strong performance in FY'22-'23. The company's Q2 numbers show growth in its VITAS segment and a decline in its Roto-Rooter segment. The econom

Although the revenue and EPS for Chemed (CHE) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street est

Chemed (CHE) came out with quarterly earnings of $4.71 per share, missing the Zacks Consensus Estimate of $5.09 per share. This compares to earnings of $4.84 per share a year ago.

Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2023, on Wednesday, July 26, 2023, following th

Investors continue to be optimistic about Chemed (CHE) on the strength of the VITAS Healthcare and Roto-Rooter segments.

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, CHE, AMED and ADUS are well poised

The latest earnings season has come and gone.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2023 Healthcare Conference on Thursday, June 8, 2023, at approximately

Investors continue to be optimistic about Chemed (CHE) on the strong performance of the VITAS Healthcare and Roto-Rooter segments.

Stock screeners can help investors identify stocks to buy based on a variety of criteria. In fact, one helpful predictor of stock price growth can be found with analyst ratings.

Chemtrade Logistics Income Fund (OTC:CGIFF) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Scott Rook - President and Chief Executive Officer Rohit Bhardwaj - Chief Fina